Topical amikacin formulation induces fibroblast growth factor and cytokine release from human dermal fibroblasts.
Baroni
A
A
Istituto di Clinica Dermosifilopatica, Facoltà di Medicina e Chirurgia II Università degli Studi di Napoli, Italy.
Perfetto
B
B
Buttini
G
G
Catalanotti
P
P
Gorga
F
F
Tufano
M A
MA
D000328:Adult; D000583:Amikacin / Q000494:pharmacology*; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002478:Cells, Cultured; D016207:Cytokines / Q000378:metabolism*; D005079:Excipients / Q000494:pharmacology; D005260:Female; D005347:Fibroblasts / Q000187:drug effects* / Q000378:metabolism; D006133:Growth Substances / Q000378:metabolism*; D006801:Humans; D007375:Interleukin-1 / Q000494:pharmacology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008875:Middle Aged; D012867:Skin / Q000166:cytology*
D000900:Anti-Bacterial Agents; D016207:Cytokines; D005079:Excipients; D006133:Growth Substances; D007375:Interleukin-1; D008070:Lipopolysaccharides; D000583:Amikacin